{
    "clinical_study": {
        "@rank": "166369", 
        "acronym": "BupPain", 
        "arm_group": [
            {
                "arm_group_label": "TOPPS Intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "Individuals randomized into this arm will receive 7 individual sessions of the Treating Opioid Patients' Pain and Sadness (TOPPS) intervention, designed to reduce symptoms of pain and depression."
            }, 
            {
                "arm_group_label": "Health Education", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Individuals randomized into this arm will receive 7 individual sessions on general health education."
            }
        ], 
        "brief_summary": {
            "textblock": "Individuals will be recruited by posted advertisements in the waiting rooms of the PCP\n      offices and by physician referral.  After an initial phone screen, research staff will meet\n      with interested individuals in their PCP offices for informed consent, baseline interview\n      and randomization. Participants will be randomized into a Health Education study arm, and\n      receive 7 individual sessions on general health education, or an Intervention study arm, and\n      receive 7 individual sessions of the Treating Opioid Patients' Pain and Sadness (TOPPS)\n      intervention."
        }, 
        "brief_title": "Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pain", 
            "Depression", 
            "Substance Use"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Chronic Pain, defined as pain duration for at least six months with a mean score of 5\n             or higher on the BPI Pain Interference Scale;\n\n          -  Pain severity of 40 or higher on a Visual Analog Scale (0-100) indicating \"worst pain\n             in the last week\";\n\n          -  Previous attempt at initial steps of PCP guideline pain care: must have had at least\n             one trial of recommended medication (i.e. acetaminophen, NSAIDS, skeletal muscle\n             relaxants) judged through interviews with patients and PCPs;\n\n          -  QIDS score of \u2265 10 (depression severity)\n\n          -  If using an antidepressant, the dose must be stable for the previous 2 months;\n\n          -  Age 18 or older\n\n          -  Has received buprenorphine/naloxone (Suboxone)for at least the last 3 months;\n\n          -  Plan to continue buprenorphine/naloxone (Suboxone)for at least 3 months.\n\n        Exclusion Criteria:\n\n          -  Lifetime DSM-IV diagnosis of bipolar disorder, schizophrenia, or other chronic\n             psychotic condition;\n\n          -  Current DSM-IV diagnosis of substance dependence for sedative/hypnotic drugs,\n             alcohol, stimulants, or cocaine;\n\n          -  Suicidal ideation or behavior requiring immediate attention;\n\n          -  In psychotherapy or in a multidisciplinary pain management program at baseline;\n\n          -  Anticipate having surgery in the next 6 months;\n\n          -  Pain thought to be due to cancer, infection, inflammatory arthritis, or associated\n             with severe or progressive neurological deficits;\n\n          -  SSDI or SSI claim pending;\n\n          -  Pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752998", 
            "org_study_id": "DA032800", 
            "secondary_id": "1205-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "TOPPS Intervention", 
                "intervention_name": "Treating Opioid Patients' Pain and Sadness (TOPPS)", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Health Education", 
                "intervention_name": "Health Education", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Buprenorphine", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pain", 
            "depression", 
            "substance use"
        ], 
        "lastchanged_date": "July 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Providence", 
                    "country": "United States", 
                    "state": "Rhode Island", 
                    "zip": "02906"
                }, 
                "name": "Butler Hospital"
            }, 
            "investigator": {
                "last_name": "Michael Stein, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings", 
        "overall_contact": {
            "email": "michael_stein@brown.edu", 
            "last_name": "Michael Stein, MD", 
            "phone": "401-455-6646"
        }, 
        "overall_official": {
            "affiliation": "Butler Hospital", 
            "last_name": "Michael Stein, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: National Institutes of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain, as measured by self-report", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "4 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752998"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Butler Hospital", 
            "investigator_full_name": "Michael Stein, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Depression, as measured by self-report and clinician-administered assessments", 
                "measure": "Depression", 
                "safety_issue": "No", 
                "time_frame": "4 months"
            }, 
            {
                "description": "Illicit substance use, as measured by self-report and urine toxicology", 
                "measure": "Substance Use", 
                "safety_issue": "No", 
                "time_frame": "4 months"
            }
        ], 
        "source": "Butler Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Butler Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}